企業一覧に戻る

ALEXANDRIA REAL ESTATE EQUITIES, INCARE)の決算・業績分析

ALEXANDRIA REAL ESTATE EQUITIES, INCの2025年有価証券報告書をAI分析。売上高$3.0B(-2.9%)。Real Estate

目次
SUMMARY — 業績サマリー

ALEXANDRIA REAL ESTATE EQUITIES, INC2025年度 業績サマリー

ALEXANDRIA REAL ESTATE EQUITIES, INC(証券コード: ARE)の2025年度決算・業績分析。売上高は$3.0B(前年比-2.9%)。純利益は-$1.4B(前年比-542.7%)。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。

ALEXANDRIA REAL ESTATE EQUITIES, INC2024年度 注目ポイント

※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。

  1. Revenue surged to $2.6B (+22.5% YoY) in FY2024, but net income declined to $522M (-8.7% YoY) with a net margin of 20.1% (XBRL).
  2. Free cash flow turned negative at $-3.8B, driven by $-5.1B in investing cash flow (XBRL).
  3. Net debt rose to $11.6B, with long-term debt at $12.2B, despite $618M in cash (XBRL).
  4. Payout ratio reached 145.2%, with $758M in dividends paid (XBRL).

ALEXANDRIA REAL ESTATE EQUITIES, INCの売上高変化の要因

  • Revenue grew from $1.3B in FY2020 to $2.6B in FY2024, reflecting a 5-year CAGR of +16.8% (XBRL). However, net income declined from $379M in FY2020 to $522M in FY2024, with a 5-year CAGR of -22.9% (XBRL). The growth in revenue is attributed to expansion of ARE's property portfolio, which includes 39.8 million RSF of operating properties and 4.4 million RSF under construction in North America (10-K).

ALEXANDRIA REAL ESTATE EQUITIES, INCの営業利益変化の要因

  • Net margin stood at 20.1% in FY2024, but net income declined by 8.7% YoY (XBRL). Operating income and gross profit were not disclosed (XBRL). Return on equity (ROE) was 2.8%, and return on assets (ROA) was 1.4%, indicating weak profitability despite revenue growth (XBRL).

ALEXANDRIA REAL ESTATE EQUITIES, INCの事業リスクと対応

Inability to complete acquisitions or operate properties profitably (10-K).

Risk of tenant defaults or lease non-renewal, with 52% of rental revenue from investment-grade tenants (10-K).

Higher-than-anticipated maintenance costs and inability to pass them to tenants (10-K).

Environmental liabilities from tenants or properties (10-K).

Reliance on limited vendors for utilities/services (10-K).

Regulatory risks, including changes in tax laws and potential failure to maintain REIT qualification (10-K).

ALEXANDRIA REAL ESTATE EQUITIES, INCの今後の見通し・業績予想

The 10-K does not provide explicit forward-looking guidance. However, historical revenue growth (CAGR of +16.8% over 5 years) and the company's focus on expanding its 'Megacampus™' ecosystems suggest continued growth potential, despite challenges in profitability and liquidity (XBRL).

ALEXANDRIA REAL ESTATE EQUITIES, INCの事業内容

ARE is a life science real estate investment trust (REIT) specializing in developing, owning, and operating Class A/A+ properties in 'Megacampus™' ecosystems located in life science innovation clusters (10-K). The company generates revenue primarily through rental income from leasing laboratory and office spaces to tenants in the life science industry, including multinational pharmaceutical companies, biotechnology firms, academic institutions, and government agencies (10-K). ARE's competitive advantages include its pioneering role in life science real estate, high occupancy rates (94.6% as of December 31, 2024), and strategic relationships in the life science sector (10-K).

ALEXANDRIA REAL ESTATE EQUITIES, INCのAI業績分析レポート(2024年度)

Alexandria Real Estate Equities, Inc. (ARE) FY2024 Annual Report Analysis

Highlights
Revenue surged to $2.6B (+22.5% YoY) in FY2024, but net income declined to $522M (-8.7% YoY) with a net margin of 20.1% (XBRL).
Free cash flow turned negative at $-3.8B, driven by $-5.1B in investing cash flow (XBRL).
Net debt rose to $11.6B, with long-term debt at $12.2B, despite $618M in cash (XBRL).
Payout ratio reached 145.2%, with $758M in dividends paid (XBRL).
Business Overview

ARE is a life science real estate investment trust (REIT) specializing in developing, owning, and operating Class A/A+ properties in 'Megacampus™' ecosystems located in life science innovation clusters (10-K). The company generates revenue primarily through rental income from leasing laboratory and office spaces to tenants in the life science industry, including multinational pharmaceutical companies, biotechnology firms, academic institutions, and government agencies (10-K). ARE's competitive advantages include its pioneering role in life science real estate, high occupancy rates (94.6% as of December 31, 2024), and strategic relationships in the life science sector (10-K).

Revenue Analysis

Revenue grew from $1.3B in FY2020 to $2.6B in FY2024, reflecting a 5-year CAGR of +16.8% (XBRL). However, net income declined from $379M in FY2020 to $522M in FY2024, with a 5-year CAGR of -22.9% (XBRL). The growth in revenue is attributed to expansion of ARE's property portfolio, which includes 39.8 million RSF of operating properties and 4.4 million RSF under construction in North America (10-K).

Profitability Analysis

Net margin stood at 20.1% in FY2024, but net income declined by 8.7% YoY (XBRL). Operating income and gross profit were not disclosed (XBRL). Return on equity (ROE) was 2.8%, and return on assets (ROA) was 1.4%, indicating weak profitability despite revenue growth (XBRL).

Balance Sheet Analysis

Total assets increased to $36.8B in FY2024, with total equity at $18.5B (XBRL). The equity ratio was 50.2%, and the debt-to-equity (D/E) ratio was 0.77x (XBRL). Net debt reached $11.6B, with long-term debt at $12.2B (XBRL). Cash reserves amounted to $618M (XBRL).

Cash Flow Analysis

Operating cash flow was $1.3B in FY2024, but free cash flow (FCF) was negative at $-3.8B (XBRL). Investing cash flow was -$5.1B, likely reflecting capital expenditures, while financing cash flow was $4.2B, driven by $758M in dividends paid (XBRL). No share repurchases were conducted (XBRL).

Working Capital Analysis

Receivables days were 1 day, indicating efficient collections (XBRL). Asset turnover was 0.07x, suggesting low efficiency in utilizing assets to generate revenue (XBRL). Data on inventory or payables days was not available (N/A).

Risks
Inability to complete acquisitions or operate properties profitably (10-K).
Risk of tenant defaults or lease non-renewal, with 52% of rental revenue from investment-grade tenants (10-K).
Higher-than-anticipated maintenance costs and inability to pass them to tenants (10-K).
Environmental liabilities from tenants or properties (10-K).
Reliance on limited vendors for utilities/services (10-K).
Regulatory risks, including changes in tax laws and potential failure to maintain REIT qualification (10-K).
Outlook

The 10-K does not provide explicit forward-looking guidance. However, historical revenue growth (CAGR of +16.8% over 5 years) and the company's focus on expanding its 'Megacampus™' ecosystems suggest continued growth potential, despite challenges in profitability and liquidity (XBRL).

Real Estateの企業一覧

ALEXANDRIA REAL ESTATE EQUITIES, INCと同じ「Real Estate」セクターの企業